Evidence map›Paper›PMID 37933646›Full record

Trial reportNan fang yi ke da xue xue bao = Journal of Southern Medical University2023

[Mechanism of Qingluo Tongbi Formula for regulating immune-bone erosion in rheumatoid arthritis].

T Liu, X Zhou, C Huang, L Zhou, X Chen, L Wan, R Zong, H Fan, Y Sun, Z Yu and 3 more

Open access · greenAbstract readRandomized Controlled TrialEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

T LiuDepartment of Rheumatology of First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China.
X ZhouFirst Clinical College, Nanjing University of Chinese Medicine, Nanjing 210000, China.
C HuangDepartment of Rheumatology of First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China.
L ZhouSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210000, China.
X ChenDepartment of Rheumatology of First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China.
L WanDepartment of Rheumatology of First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China.
R ZongDepartment of Rheumatology of First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China.
H FanDepartment of Rheumatology of First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China.
Y SunDepartment of Rheumatology of First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China.
Z YuFirst Clinical College, Nanjing University of Chinese Medicine, Nanjing 210000, China.
Z TangGraduate School, Anhui University of Chinese Medicine, Hefei 230031, China.
G XuGraduate School, Nanjing University of Chinese Medicine, Nanjing 210000, China.
Z ZhouGraduate School, Nanjing University of Chinese Medicine, Nanjing 210000, China.
Anhui University of Traditional Chinese Medicine · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the mechanism of

methodsSixty-four RA patients were randomized into two groups to receive treatment with oral methotrexate or

resultsThe B cell subgroups in RA patients were correlated with the RANKL/RANK/OPG system. Treatment with

conclusion

Indexed as

Arthritis, RheumatoidDrugs, Chinese HerbalHumansMethotrexateOsteoclastsOsteoprotegerinRANK LigandTartrate-Resistant Acid PhosphataseDrugs, Chinese HerbalMethotrexateOsteoprotegerinqingluo tongbiRANK LigandTartrate-Resistant Acid Phosphataseimmune-bone erosionQingluo Tongbi Formularheumatoid arthritis

Identifiers

PMID37933646
PMCPMC10630194
OpenAlexW4388466240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.